Please use this identifier to cite or link to this item:
Title: Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia [Oncotarget, 8 (2017) (29679-29698)] Doi: 10.18632/oncotarget.11425
Authors: Guerra, Borja 
Martín-Rodríguez, Patricia
Díaz-Chico, Juan Carlos 
McNaughton-Smith, Grant
Jiménez-Alonso, Sandra
Hueso-Falcón, Idaira
Montero, Juan Carlos
Blanco, Rosa
León, Javier
Rodríguez-González, Germán
Estévez-Braun, Ana
Pandiella, Atanasio
Díaz-Chico, Bonifacio Nicolás 
Fernández-Pérez, Leandro 
Issue Date: 2018
Journal: Oncotarget 
Abstract: © Guerra et al.This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
DOI: 10.18632/oncotarget.26008
Source: Oncotarget,v. 9, p. 32272-32272
Appears in Collections:Artículos
Show full item record

Page view(s)

checked on May 17, 2021

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.